Strategy for prevention from development and progression of diabetic retinopathy
Ando, N.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70 Suppl. 5: 378-383
2012
ISSN/ISBN: 0047-1852 PMID: 23156423 Document Number: 659794
Document emailed within 1 workday
Related Documents
Funatsu, H.; Yamashita, H. 2002: Molecular biology in development and progression of diabetic retinopathy Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 10): 162-166Ishibashi, T.; Tanaka, K.; Taniguchi, Y. 1979: An experimental study on the role of vascular permeability in the development and progression of diabetic retinopathy Nippon Ganka Gakkai Zasshi 83(7): 783-794
Latinović, S. 1984: Prevention of its development and treatment possibilities in diabetic retinopathy Medicinski Pregled 37(11-12): 551-557
Funatsu, H.; Hori, S.; Ohashi, Y.; Ishigaki, T. 1993: Risk factors for occurrence and progression of diabetic retinopathy Nippon Ganka Gakkai Zasshi 97(8): 939-946
Miyamoto, K.; Ogura, Y. 2002: Diabetic retinopathy and leukocytes--feasibility of anti-leukostasis therapy for diabetic retinopathy Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 10): 183-188
Ecker-Schlipf, B. 2000: Prevention and therapy of diabetic retinopathy Medizinische Monatsschrift für Pharmazeuten 23(11): 378-380
Sato, Y.; Ohkuma, K.; Kamata, A.; Matsui, M. 1984: Clinical studies on macular changes in diabetic retinopathy. Part 3. Studies on pathology of retinal capillary beds in and around the macula in diabetic retinopathy Nippon Ganka Gakkai Zasshi 88(7): 1084-1092
Balashova, L.M. 1999: The morphological characteristics and immunohemostatic mechanisms of the development of diabetic retinopathy Vestnik Oftalmologii 115(5): 45-48
Adamiec, J.; Oficjalska-Młyńczak, J. 2005: The role of anti-pericyte antibodies in the development of diabetic retinopathy Klinika Oczna 107(7-9): 541-543
Raju, M.; Pagidimarri, V.; Barreto, R.; Kadam, A.; Kasivajjala, V.; Aswath, A. 2017: Development of a Deep Learning Algorithm for Automatic Diagnosis of Diabetic Retinopathy Studies in Health Technology and Informatics 245: 559-563
Galetović, D.; Karlica, D.; Bućan, K.; Znaor, L. 2008: The role of clinical and metabolic factors in the genesis and development of diabetic retinopathy Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 62(1): 23-27
Ziablitsev, S.V.; Korobova, A.V.; Petrenko, O.V.; Serduk, V.N.; Mogilevsky, S.U. 2016: Role of matrix metalloproteinase 9 and its tissue inhibitor 1 in development and prognosis of diabetic retinopathy Fiziolohichnyi Zhurnal 62(5): 37-44
De Simone, R.; Greco, A.; Greco, G.; De Crecchio, G.; Montefusco, S.; Iovine, C.; Rivellese, A.; Riccardi, G.; Mancini, M. 1986: Factors influencing the development of proliferative diabetic retinopathy treated by laser therapy Recenti Progressi in Medicina 77(5): 237-240
Nicholls, K. 2007: Prevention of progression of kidney disease: diabetic nephropathy - CARI guidelines Australian Family Physician 36(3): 137-138
Kliaczko, W.R.; Tirkina, T.N.; Michajlowa, N.A. 1970: Influence of clinical characteristics of diabetes upon the development and course of diabetic retinopathy with particular reference to anabolic steroid therapy Endokrynologia Polska 21(4): 383-392
Endo, H.; Naito, T.; Asahara, T.; Kajima, M.; Shiota, H. 2000: Cytokines in the vitreous fluid of patients with proliferative diabetic retinopathy--vascular endothelial growth factor and platelet-derived growth factor are elevated in proliferative diabetic retinopathy Nippon Ganka Gakkai Zasshi 104(10): 711-716
Ermakova, N.A.; Syrodeeva, O.N.; Antsiferov, M.B.; Balatskaia, N.V.; Krasnova, L.B. 2008: Role of vascular endothelial growth factor in the development of diabetic retinopathy in patients with type 1 diabetes mellitus Vestnik Oftalmologii 124(1): 25-28
Kalvodová, B. 2013: Present state of diagnostic and screening of the diabetic retinopathy and diabetic macular oedema Vnitrni Lekarstvi 59(3): 182-186
Meyer-Schwickerath, E.; Scheider, A.; Thurau, S.R.; Ulbig, M.; Landgraf, R.; Kampik, A.; Land, W. 1993: Does combined pancreas-kidney transplantation modify diabetic retinopathy in type-1 diabetic patients? Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 90(3): 283-288
El-Diasty, A.M.; Shahin, M. 2008: Anticardiolipin antibodies in diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy Egyptian Journal of Immunology 15(1): 101-107